Abstract
Background
Bovine herpesvirus 4 (BoHV-4) is a useful model for the human pathogenic gammaherpesviruses Epstein-Barr virus and Kaposi's Sarcoma-associated Herpesvirus. Although genome manipulations of this virus have been greatly facilitated by the cloning of the BoHV-4 V.test strain as a Bacterial Artificial Chromosome (BAC), the lack of a complete genome sequence for this strain limits its experimental use.
Methods
In this study, we have determined the complete sequence of BoHV-4 V.test strain by a pyrosequencing approach.
Results
The long unique coding region (LUR) consists of 108,241 bp encoding at least 79 open reading frames and is flanked by several polyrepetitive DNA units (prDNA). As previously suggested, we showed that the prDNA unit located at the left prDNA-LUR junction (prDNA-G) differs from the other prDNA units (prDNA-inner). Namely, the prDNA-G unit lacks the conserved pac-2 cleavage and packaging signal in its right terminal region. Based on the mechanisms of cleavage and packaging of herpesvirus genomes, this feature implies that only genomes bearing left and right end prDNA units are encapsulated into virions.
Conclusions
In this study, we have determined the complete genome sequence of the BAC-cloned BoHV-4 V.test strain and identified genome organization features that could be important in other herpesviruses.
Background
Gammaherpesviruses are archetypal persistent viruses which are ubiquitous in both human and animal populations. The human gammaherpesviruses, Epstein-Barr virus (EBV) and Kaposi's Sarcoma-associated Herpesvirus (KSHV), infect respectively some 90% [1] and 30% [2] of human populations and cause several cancers [2,3]. Although much effort has been invested on these viruses, studies of EBV or KSHV are difficult to perform directly because these viruses show limited lytic growth in vitro and have no well-established in vivo infection model. Related animal gammaherpesviruses are therefore an important source of information.
Bovine herpesvirus 4 (BoHV-4) belongs to the Gammaherpesvirinae subfamily, and to the Rhadinovirus genus [4]. Similarly to its human counterparts, BoHV-4 was found to be widespread in all bovine populations and to persist in the vast majority of individuals as a lifelong, asymptomatic infection [5]. However, in some circumstances, BoHV-4 has been associated with various clinical symptoms such as skin lesions, respiratory diseases, metritis, malignant catarrhal fever or tumors [5].
The virus was first isolated in Europe by Bartha et al. from calves with respiratory diseases [6] and later in North America by Mohanty et al. [7]. Besides cattle, BoHV-4 has also been detected in a variety of ruminants. In particular, BoHV-4 seems to be highly prevalent among wild African buffalo (Syncerus caffer) which could be considered as the natural reservoir of the virus [8-10]. Overall, more than 40 BoHV-4 strains have been isolated across the world. These strains can be classified in three groups: the European strains (or Movar 33/63-like strains), the American strains (or DN 599-like strains) and the African buffalo strains [9].
It is estimated that the taurine and buffalo strains diverged around 730,000 years ago [9] and that the European and North American clades diverged around 260,000 years ago [9]. The genome of the BoHV-4 66-p-347 North American strain has entirely been sequenced [11]. However, the BAC-cloned reference strain V.test [12,13] belongs to the European clade [9,14]. Previous studies suggested that the BoHV-4 V-test strain contains regions of high dissimilarity compared to the BoHV-4 66-p-347 strain. Indeed, the nucleotide identity between the two strains has been previously measured to be as low as 88% on the BORFB2 region [11]. However, the lack of a complete genomic sequence for the V.test strain prevents from drawing a general view concerning this divergence level. Therefore, the low quality of the genomic information hampers the use of the BAC-cloned BoHV-4 V.test strain as a good model for studying gammaherpesvirus biology. In this study, we have determined the genomic sequence of the BoHV-4 V.test strain and analyzed its overall differences with the available sequence of the BoHV-4 66-p-347 strain [11,15]. The results obtained highlighted important differences between BoHV-4 66-p-347 and V.test strains. Moreover complete sequencing of the BoHV-4 V.test strain also revealed genome features potentially important in other herpesviruses.
Methods
BAC sequencing
BAC DNA was purified using Qiagen large-construct kit as described by the manufacturer. The complete BAC cloned viral genome of BoHV-4 V.test strain was determined by pyrosequencing using the 454 GS FLX Titanium (Roche) high-throughput sequencer and resulted in 48,967 reads of an average read length of 265 nucleotides and a total of 12,997,275 bases. A targeted ABI-Sanger sequencing of fragments of the prDNA region was also conducted using the primers listed in Table 1. The raw 454 data has been deposited in the NCBI Sequence Read Archive (SRA) database with accession number SRA037246.
Table 1.
name | Sequence | Coordinates according to Genbank |
---|---|---|
Bo1 Fwd | 5'- ATGGAGGGTGATGGATTCATG-3' | 460-440a |
Bo1 Rev | 5'- TTAAGGCCTCATTCCAGGAAG-3' | 272-292a |
Bo5 Fwd | 5'- GCTACAGAAAATGGCCAGTAAAG-3' | 20366-20342a |
Bo5 Rev | 5'- TCATGTCCTGAGTGGGTCTATG-3' | 19170-19191a |
Bo6 Fwd | 5'- ATGGTCATCCTAAATGCTCAAG -3' | 20297-20318a |
Bo6 Rev | 5'- TCACCTAGTGTTGCAACCCC -3' | 20497-20478a |
Bo7 Fwd | 5'- ATGGAGACAATTTCCATAAACTG -3' | 20994-20972a |
Bo7 Rev | 5'- CTAGCTGGGGTAGAGTGATC -3' | 20671-20690a |
ORF67.5 Fwd | 5'- ATGGCTGATGGTGATGTTTTAG -3' | 93144-93123a |
ORF67.5 Rev | 5'- TCAATGTTTGTCCAGAGCACT -3' | 92881-92901a |
Bo12 Fwd | 5'- ATGGGGGCGCTATTTGGGC -3' | 97442-97460a |
Bo12 Rev | 5'- TCAACTGATGAAACCCACCC -3' | 97525-97506a |
Bo13 Fwd | 5'- ATGCGTCTCGATGGCAAGC -3' | 98838-98856a |
Bo13 Rev | 5'- CTATGGTTGTTTTTTAAAGAAAATC -3' | 98981-98957a |
ORF75 Fwd | 5'- ATGTATCCCAGATACAGTAACA -3' | 103606-103585a |
ORF75 Rev | 5'- TTACATTTTATTTTTCAGACACCA -3' | 100274-100297a |
prDNA Fwd 1 | 5'- GGAGCCCAAAACCAAAAGAG -3' | 870-889b |
prDNA Rev 1 | 5'- CTCTTTTGGTTTTGGGCTCC -3' | 889-870b |
prDNA Fwd 2 | 5'- CGTAGGCCTCACATTCAGC -3' | 908-926b |
prDNA Rev 2 | 5'- GCTGAATGTGAGGCCTACG -3' | 926-908b |
prDNA Fwd 3 | 5'- CGAGAGATGGTTCTTGCACA -3' | 940-959b |
prDNA Rev 3 | 5'- TGTGCAAGAACCATCTCTCG -3' | 959-940b |
BAC Rev | 5'- TTGCCAATCCCAAAAAGAAG -3' | 9859-9878c |
a according to Genbank JN133502 sequence (BoHV-4 V.test strain long unique region)
b according to Genbank JN133504 sequence (BoHV-4 V.test strain prDNA inner region)
c according to Genbank AY665170.1 sequence (pBeloBAC modified)
BoHV-4 genome LUR assembly
The reads were de novo assembled with gsAssembler (Roche), where the E. coli genome was used as a contaminant to filter out cellular reads [16]. The filtering removed 1,167 contaminant cellular reads. The de novo assembly yielded 11 contigs which were subsequently BLASTed against 66-p-347's long unique region (LUR) and polyrepetitive DNA (prDNA) -accession numbers NC_002665 and AF092919- to define their relative positions [17]. Contigs were assembled into a large scaffold using two previously published V.test sequences (accession numbers Z46380 and Z46385 [18]) overlapping contig borders. A careful comparison of the bordering contigs with the previously sequenced fragments showed a high percent identity (> 99.99%). After verification of the quality of the assembly, the BAC sequence was removed and the genome sequence was annotated as detailed hereunder.
BoHV-4 genome prDNA assembly
The prDNA was determined by a hybrid 454/ABI-Sanger strategy where 17 ABI-Sanger fragments of prDNA were de novo assembled with the 454 reads. Briefly, in order to correctly assemble the prDNA and to disentangle different prDNA units, this second de novo assembly was optimized for highly repetitive segments using MIRA [19]. 454 reads and quality information were extracted from the raw .sff file with 'sff_extract'. The base-calling and quality-calling for Sanger sequences were inferred from the .ab1 raw chromatogram files using 'phred' [20,21] and the sequences were quality-trimmed using 'lucy' [22]. MIRA assembler (v 3.2.0) was used to build an assembly of the V.test genome with the following flags and options: "-job = denovo, genome, accurate, sanger, 454 -highlyrepetitive -AS:klrs = no 454_SETTINGS -AS:urdcm = 1.1:ardml = 100''. This assembly yielded a very large contig containing a complete prDNA unit, and a second contig containing an incomplete unit bearing the prDNA/prDNA junction. The complete prDNA unit was extracted from the first contig and identified as being the last prDNA unit before the LUR junction and noted prDNA-G following Bublot et al. [14]. By analysing the contig bearing the prDNA/prDNA junction in GAP4 [23], we determined a 518 bp fragment of the prDNA-inner unit (as named by Bublot et al. [14]) bordered on the left by lower read qualities and coverage, and on the right by the beginning of a new prDNA unit. This end was joined to the beginning (2,089 bp) of the prDNA-G unit in order to obtain a complete prDNA-inner unit (2,607 bp). We verified that this complete unit was compatible with previously published information [14].
BoHV-4 genome annotation
All Open Reading Frames (ORFs) from all 6 frames were retrieved from the complete genomic sequence and matched against the Conserved Domain Database [24] using the position-specific scoring matrices (PSSM) based Reverse PSI-BLAST [25]. For all ORFs sharing the same STOP and containing a PSSM match, the smallest ORF containing the largest PSSM match was retained. 59 ORFs were thus considered evolutionarily conserved and were annotated with the corresponding matching conserved domains. Out of the 79 CDS from the previously published 66-p-347 strain, all 59 ORFs matched previously annotated 66-p-347 ORFs. The 20 remaining CDS were added by similarity to this strain and were annotated as such. Repeat segments and special features were annotated according to 66-p-347 if they were present in V.test. The complete genome sequence containing the LUR, prDNA-G and prDNA-inner were annotated and submitted to GenBank with respective accession numbers: JN133502, JN133503 and JN133504.
Comparative genomics analysis of 66-p-347 and V.test
The LUR and prDNA sequences of the 66-p-347 strain were joined into a complete genome (accession numbers NC_002665 and AF092919) and aligned against the joined LUR and prDNA-inner V.test sequences with ClustalW 2.0.10 [26]. Percent divergence, percent insertions and deletions, and percent G+C content were computed (i) along the alignment on a 100 bp sliding window of step 3 bp and (ii) on all individually aligned proteins. Analyses and figures were conducted using R [27] and the seqinr [28] package in combination with ad hoc programs written in Python and using the Biopython libraries [29,30].
RT-PCR analysis
These experiments were performed as described elsewhere [31]. Briefly, subconfluent monolayers of MDBK cells were infected with BoHV4 V.test strain at a m.o.i. of 1 PFU/cell. 18 hours after infection, cytoplasmic RNA was extracted, purified and treated for RT-PCR. The cDNA products were amplified by PCR using specific primers listed in Table 1.
Results and discussion
BAC sequencing and genome assembly
Pyrosequencing of herpesviral genomes is often limited by the high concentration of contaminating cellular DNA [32]. We therefore prepared the BoHV-4 V.test strain DNA from BAC maintained genomes and sequenced it using a high-throughput pyrosequencing approach [16]. This yielded 48,967 reads among which 47,800 were BoHV-4 specific (> 97% of the reads). After assembly, the mean genome coverage was of the order of 96×. In comparison to the whole genome sequencing of another herpesvirus based on DNA isolated from virus particles, which exhibited a 13× average base pair coverage [32], our strategy showed a more than 7-fold increase. This is probably mainly due to the high proportion of viral to cellular reads present in our dataset. Indeed, only 1,167 Escherichia coli contaminant reads had to be discarded from the data, indicating less than 2.38% of contaminated reads, compared to the previously reported 62.72% contaminating cellular reads in [32]. Our sequencing strategy based on a BAC cloning approach, thus revealed itself very powerful in terms of contamination and subsequent coverage.
V.test genome analysis and comparison to other BoHV-4 strains
The BoHV-4 genome has a B-type structure consisting of a long unique region (LUR) flanked by several polyrepetitive DNA units (prDNA). We assembled the complete LUR of the V.test strain BoHV-4 genome into a 108,241 bp sequence. The average G+C content is of 41.21%. This value as well as the G+C% variation observed on Figure 1 is in agreement with previously reported results on the 66-p-347 strain, namely on the high G+C content of R2a region [11]. The observed-to-expected CpG ratio is of 0.225 on the LUR and is compatible with the value measured on Bos taurus (0.234) [33] suggesting (i) a high degree of methylation of CpG nucleotides and (ii) similar methylation mechanisms acting on the viral and cellular genome.
As expected, the nucleotide identity between our assembled genome and previously published V.test strain sequence data was of 99.55% in average, falling into the ranges of comparison between 454 and Sanger sequencing [34].
Compared to the 66-p-347 strain, the V.test strain had previously shown divergence up to 12% on the region surrounding BORFB2 (ORF 16, v-Bcl-2) [11]. However, the lack of a complete genomic sequence for the V.test strain prevented from drawing a general conclusion concerning this divergence level. Compared to 66-p-347 strain, the overall V.test nucleotide identity is high (99.1%), but shows a large variability at the genome level (Figure 1). As expected, the repetitive regions contained in the LUR (R1, R2a and R2b) exhibit a high nucleotide divergence, up to more than 40%, as well as large gaps (Figure 1). This indicates that the very high divergence levels seem confined to specific repetitive genomic regions. However, some rather high divergence levels were also identified in other regions (Figure 1) and namely in ORF-containing regions such as ORF 10, Bo5, ORF 57, and ORF 68 region. We also note a large deletion and a high divergence at the beginning of the LUR compared to the 66-p-347 strain. Overall, these differences in protein-coding region as well as in repetitive regions that bear predicted microRNA coding sequences [35] will require specific experiments to identify possible links with observed phenotypic differences between strains.
Conserved protein-coding genes
In order to develop an ab initio approach of gene annotation, we extracted all possible ORFs in all 6 frames from the complete genomic sequence of the BoHV-4 V.test strain. On each of these ORFs, we ran a Reverse PSI-BLAST [25] against all protein domains from the Conserved Domain Database [24]. ORFs containing an evolutionarily conserved domain were defined as the smallest ORF containing the longest CDD match (see Methods). This approach revealed 59 ORFs containing a conserved CDD domain (Table 2). All 59 detected ORFs corresponded to ORFs previously annotated in the 66-p-347 strain (on a total of 79 ORFs listed in Table 3), indicating that 75% of BoHV-4 ORFs contain conserved domains. Most of these ORFs (37/59) contain domains that are either conserved at different levels in the Herpesvirales (either gammaherpesvirinae, herpesviridae or herpesvirales), or at a much larger scale that include Eukaryota, Bacteria and Archaea (22/59) (Table 2). This second set of genes might bear good candidates for genes having been the stage of lateral gene transfer events as observed for several herpesvirus genes [36] such as the BoHV-4 Bo17 gene that encodes a homologue of the cellular core 2 beta -1,6-N-acetylglucosaminyl-transferase M [37]. These results will deserve further studies to identify the evolutionary history responsible for these observations.
Table 2.
BoHV-4 ORF | Domain accession number | Functional annotation | Species distributiona |
---|---|---|---|
ORF 3 | COG0046, TIGR01735, TIGR01736, TIGR01739, PF02769 | Phosphoribosylformylglycinamidine (FGAM) synthase; AIR synthase related protein | Eukaryota; Bacteria; Archaea; Viruses |
ORF 6 | PF00747 | ssDNA binding protein | Herpesviridae |
ORF 7 | PF01366 | Protein transporter activity | Herpesviridae |
ORF 8 | PF00606 | Surface glycoprotein | Herpesviridae |
ORF 9 | COG0417, TIGR00592, PF00136, PF03104, SM00486 | DNA polymerase type-B family | Eukaryota; Bacteria; Archaea; Viruses |
ORF 10 | PF04797 | dUTPase | Herpesviridae |
Bo4 | COG5183, SM00744 | Protein involved in mRNA turnover and stability; zinc-finger RING-variant domain | Eukaryota; Bacteria |
ORF 16 | SM00337 | BCL (B-Cell lymphoma); contains BH1, BH2 regions | Eukaryota; Bacteria; Viruses |
ORF 17 | PF00716 | Serine-type endopeptidase activity | Herpesviridae |
ORF 18 | PF03049 | UL79 family | Herpesviridae |
ORF 19 | PF01499 | Virus penetration and capsid assembly | Herpesviridae |
ORF 20 | PF01646 | UL24 family | Herpesviridae |
ORF 21 | PF00693, PF01712, PF08465 | ATP binding; thymidine kinase activity; phosphotransferase activity | Eukaryota; Bacteria; Viruses |
ORF 22 | PF02489 | Virion associated envelope glycoprotein | Herpesviridae |
ORF 23 | PF04682 | BTRF1 protein conserved region | Herpesviridae |
ORF 24 | PF03043 | UL87 family | Herpesviridae |
ORF 25 | PF03122 | Structural molecule activity | Herpesvirales |
ORF 26 | PF01802 | Structural molecule activity | Herpesvirales |
ORF 29 | PF02499, PF02500 | Probable role in DNA packaging | Herpesvirales |
ORF 30 | PF05338 | Unknown function (DUF717) | Gammaherpesvirinae |
ORF 31 | TIGR01234, PF03048 | UL92 family; L-ribulokinase | Herpesvirales; Embryophyta |
ORF 32 | PF04559 | DNA cleavage and packaging | Herpesviridae |
ORF 33 | PF03044 | Possible role in capsid maturation | Herpesviridae |
ORF 34 | PF03038 | UL95 family | Herpesviridae |
ORF 35 | PF05852 | Unknown function (DUF848) | Gammaherpesvirinae |
ORF 36 | COG0515, PF00069, SM00220 | ATP binding; protein kinase activity; Serine/threonine protein kinase | Eukaryota; Bacteria; Archaea |
ORF 37 | PF01771, PF09588 | Exonuclease activity; DNA binding | Eukaryota; Bacteria; Viruses |
ORF 38 | PF10813 | Unknown function (DUF2733) | Herpesviridae |
ORF 39 | PF01528 | Integral membrane protein | Herpesviridae |
ORF 40 | PF03324 | Helicase-primase complex associated protein | Herpesviridae |
ORF 41 | PF05774 | Helicase-primase complex components | Gammaherpesvirinae |
ORF 42 | PF01677 | UL7-like protein | Herpesviridae |
ORF 43 | PF01763 | Possible role in cleavage and packaging | Herpesviridae |
ORF 44 | COG0507, PF02689 | Helicase; ATP-dependent exoDNAse (exonuclease V) | Eukaryota; Bacteria; Viruses |
ORF 46 | COG0692, TIGR00628, TIGR03443, PF03167 | Uracil DNA glycosylase | Eukaryota; Bacteria; Archaea; Viruses |
ORF 47 | PF11108 | Glycoprotein L | Herpesviridae |
ORF 48 | PF05734 | Unknown function (DUF832) | Herpesviridae |
ORF 50 | PF03326, PF04793 | Early-intermediate transcription factors | Gammaherpesvirinae |
Bo10 | PF05459, PF05812 | Transcriptional regulator proteins | Herpesviridae |
ORF 53 | PF03554 | Highly polymorphic glycoprotein | Herpesviridae |
ORF 54 | COG0756, TIGR00576, PF00692 | dUTPase | Eukaryota; Bacteria; Archaea; Viruses |
ORF 55 | PF04533 | U44 protein | Herpesviridae |
ORF 56 | PF03121 | UL52/UL70 DNA primase | Eukaryota; dsDNA Viruses |
ORF 57 | PF04633 | BMRF2 protein | Gammaherpesvirinae |
ORF 59 | PF04929 | DNA replication accessory factor | Gammaherpesvirinae |
ORF 60 | COG0208, PF00268 | Ribonucleotide reductase | Eukaryota; Bacteria; Archaea; Viruses |
ORF 61 | COG0209, TIGR02504, TIGR02506, TIGR02510, PF00317, PF02867 | Ribonucleotide reductase | Eukaryota; Bacteria; Archaea; Viruses |
ORF 62 | PF03327 | Capsid shell protein VP19C | Herpesviridae |
ORF 63 | PF04523 | Tegument protein U30 | Herpesviridae |
ORF 64 | PF04843 | Tegument protein, N-terminal conserved region | Herpesviridae |
ORF 65 | PF06112 | Capsid protein | Gammaherpesvirinae |
ORF 66 | PF03117 | UL49 family | Herpesviridae |
ORF 67 | PF04541 | Virion protein U34 | Herpesviridae |
ORF 67.5 | PF03581 | UL33-like protein | Herpesviridae |
ORF 68 | PF01673 | Putative major envelope glycoprotein | Herpesviridae |
ORF 69 | PF02718 | UL31-like protein | Herpesviridae |
ORF 71 | PF01335, SM00031 | Death effector domain | Eukaryota; Viruses |
ORF 75 | COG0046, COG0047, TIGR01735, TIGR01736, TIGR01739, TIGR01857, PF02769 | Phosphoribosylformylglycinamidine (FGAM) synthase; AIR synthase related protein | Eukaryota; Bacteria; Archaea; Viruses |
Bo17 | PF02485 | Core-2/I-Branching enzyme | Eukaryota; Bacteria; Viruses |
Conserved functional domains were determined for each BoHV-4 V.test ORF using METHOD and the domains accession numbers, functional annotation and the species distribution were listed. When several domains were conserved, the annotations were either merged when possible or juxtaposed. Domains present in herpesviridae conserved gene families are highlighted in bold (from Fu, 2008). (PFxxx: Pfam Accession Number; SMxxx: SMART Accession Number; COGxxx: COG Accession Number; TIGRxxx: TIGRFam Accession Number).
a Major taxonomic groups.
Table 3.
BoHV-4 ORF | Strand | Starta | Stopa | HHV-8 homologueb | HHV-1 homologuec | Annotation and comments |
---|---|---|---|---|---|---|
Bo1 | - | 272 | 460 | -- | -- | Early in-frame STOP codon |
ORF 3 | + | 441 | 4307 | -- | -- | BORFA1; v-FGAM-synthase |
Bo2 | + | 4435 | 4638 | -- | -- | |
Bo3 | + | 5072 | 5299 | -- | -- | |
ORF 6 | + | 5703 | 9107 | ORF 6 | UL 29 | single-stranded DNA-binding protein MDBP |
ORF 7 | + | 9112 | 11190 | ORF 7 | UL 28 | transport protein |
ORF 8 | + | 11180 | 13804 | ORF 8 | UL 27 | glycoprotein B |
ORF 9 | + | 13944 | 16961 | ORF 9 | UL 30 | DNA polymerase |
ORF 10 | + | 17057 | 18337 | ORF 10 | -- | BORFB1 |
Bo4 | - | 18604 | 19101 | -- | -- | short ORF of immediate early transcript 1 |
Bo5 | - | 19170 | 20355 | K5 | -- | long ORF of immediate early transcript 1 |
Bo6 | + | 20297 | 20590 | -- | -- | Early in-frame STOP codon |
Bo7 | - | 20670 | 20994 | -- | -- | Disrupted frame |
Bo8 | + | 21318 | 21521 | -- | -- | overlapping with late 1.7 kb RNA |
ORF 16 | + | 22967 | 23647 | ORF 16 | -- | BORFB2; v-Bcl-2 protein |
ORF 17 | - | 23710 | 25260 | ORF 17 | UL 26 | capsid protein |
ORF 18 | + | 25259 | 26077 | ORF 18 | -- | |
ORF 19 | - | 26029 | 27705 | ORF 19 | UL 25 | tegument protein |
ORF 20 | - | 27407 | 28219 | ORF 20 | UL 24 | |
ORF 21 | + | 28203 | 29540 | ORF 21 | UL 23 | thymidine kinase |
ORF 22 | + | 29551 | 31674 | ORF 22 | UL 22 | glycoprotein H |
ORF 23 | - | 31671 | 32873 | ORF 23 | -- | |
ORF 24 | - | 32851 | 35109 | ORF 24 | -- | |
ORF 25 | + | 35099 | 39220 | ORF 25 | UL 19 | major capsid protein |
ORF 26 | + | 39256 | 40170 | ORF 26 | UL 18 | capsid protein |
ORF 27 | + | 40184 | 40829 | ORF 27 | -- | |
Bo9 | + | 40831 | 41130 | -- | -- | |
ORF 29 | - | 41154 | 46328 | ORF 29 | UL 15 | cleavage/packaging protein |
ORF 30 | + | 42306 | 42548 | ORF 30 | -- | |
ORF 31 | + | 42482 | 43123 | ORF 31 | -- | |
ORF 32 | + | 43069 | 44439 | ORF 32 | UL 17 | viral DNA cleavage/packaging protein |
ORF 33 | + | 44432 | 45430 | ORF 33 | UL 16 | |
ORF 34 | + | 46327 | 47313 | ORF 34 | -- | |
ORF 35 | + | 47285 | 47758 | ORF 35 | -- | |
ORF 36 | + | 47787 | 48950 | ORF 36 | UL 13 | kinase |
ORF 37 | + | 48958 | 50427 | ORF 37 | UL 12 | alkaline exonuclease |
ORF 38 | + | 50379 | 50585 | ORF 38 | -- | |
ORF 39 | - | 50652 | 51761 | ORF 39 | UL 10 | glycoprotein M |
ORF 40 | + | 51877 | 53247 | ORF 40 | UL 8 | helicase-primase complex component |
ORF 41 | + | 53360 | 53881 | ORF 41 | -- | helicase-primase complex component |
ORF 42 | - | 53873 | 54748 | ORF 42 | UL 7 | |
ORF 43 | - | 54525 | 56375 | ORF 43 | UL 6 | capsid protein |
ORF 44 | + | 56323 | 58701 | ORF 44 | UL 5 | helicase |
ORF 45 | - | 58805 | 59530 | ORF 45 | -- | |
ORF 46 | - | 59530 | 60291 | ORF 46 | UL 2 | uracil-DNA-glycosidase |
ORF 47 | - | 60309 | 60731 | ORF 47 | -- | glycoprotein L |
ORF 48 | - | 60838 | 62382 | ORF 48 | -- | |
ORF 50 | + | 62586 | 65179 | ORF 50 | -- | immediate early transcript 2; R transactivator protein |
ORF 49 | - | 62600 | 63499 | ORF 49 | -- | |
Bo10 | + | 65696 | 66595 | -- | UL 54 | glycoprotein gp80 |
ORF 52 | - | 66621 | 67007 | ORF 52 | -- | |
ORF 53 | - | 67073 | 67345 | ORF 53 | -- | |
ORF 54 | + | 67414 | 68262 | ORF 54 | UL 50 | dUTPase |
ORF 55 | - | 68321 | 68923 | ORF 55 | -- | |
ORF 56 | + | 68887 | 71418 | ORF 56 | UL 52 | DNA replication protein |
ORF 57 | + | 71512 | 72870 | ORF 57 | -- | possible post-transcriptional transactivator |
ORF 58 | - | 73294 | 74346 | ORF 58 | -- | |
ORF 59 | - | 74360 | 75535 | ORF 59 | -- | DNA replication protein |
ORF 60 | - | 75688 | 76605 | ORF 60 | UL 40 | ribonucleotide reductase small subunit |
ORF 61 | - | 76639 | 79020 | ORF 61 | UL 39 | ribonucleotide reductase large subunit |
ORF 62 | - | 79002 | 80021 | ORF 62 | UL 38 | assembly/DNA maturation protein |
ORF 63 | + | 79978 | 82797 | ORF 63 | -- | tegument protein |
ORF 64 | + | 82812 | 90488 | ORF 64 | UL 36 | tegument protein |
ORF 65 | - | 90504 | 90896 | ORF 65 | -- | capsid protein |
ORF 66 | - | 90893 | 92167 | ORF 66 | -- | |
ORF 67 | - | 92107 | 92877 | ORF 67 | UL 34 | tegument protein |
ORF 67.5 | - | 92881 | 93144 | ORF 67.5 | UL 33 | Disrupted (late) methionine |
ORF 68 | + | 93155 | 94504 | ORF 68 | UL 32 | probable glycoprotein |
ORF 69 | + | 94512 | 95405 | ORF 69 | UL 31 | |
Bo11 | - | 96158 | 96703 | -- | -- | |
Bo12 | + | 97442 | 97684 | -- | -- | Early in-frame STOP codon |
ORF 71 | - | 98328 | 98876 | K13/ORF 71 | -- | BORFE2; v-FLIP |
Bo13 | + | 98838 | 98983 | -- | -- | Disrupted frame |
ORF 73 | - | 99022 | 99783 | ORF 73 | -- | BORFE3, LANA homologous |
ORF 75 | - | 100274 | 103606 | ORF 75 | -- | Disrupted (late) methionine; tegument protein/v-FGAM-synthetase |
Bo14 | - | 104273 | 104785 | -- | -- | |
Bo15 | - | 105724 | 106038 | -- | -- | |
Bo16 | + | 106225 | 106494 | -- | -- | |
Bo17 | + | 106681 | 108003 | -- | -- | viral beta-1,6-N-acetylglucosaminyltransferase |
a Positions of the respective ORFs of BoHV-4 on the LUR sequence. These are given from the first nucleotide of the start codon ATG to the last nucleotide of the stop codon.
b Correspondance to HHV-8 genes is according to Zimmermann (2001).
c Correspondance to HHV-1 genes was based on the presence of conserved domain with a BoHV-4 gene. Genes containing evolutionary conserved domains are highlighted in bold italic. The genes conserved in Herpesviridae are highlighted in bold (from Fu, 2008).
Non-conserved protein-coding genes
The remaining 20 annotated ORFs were determined by similarity to the 66-p-347 strain, and correspond for most of them to ORFs unique to BoHV-4 as described previously (Table 3) [11]. Some of these ORFs, however, contain odd characteristics that needed to be investigated (Figure 2, Additional file 1 Figures S1-9). Indeed Bo1, Bo6, Bo7, Bo12 and Bo13 genes of the BoHV-4 V.test strain present in-frame STOP codons. Bo5 presents rather high divergency levels and large insertions/deletions (> 5% of its coding sequence as shown in Figure 2) compared to the genomic sequence of the 66-p-347 strain. Moreover, ORFs 36, 67.5 and 75, which bear an evolutionary conserved domain, present late methionines compared to the 66-p-347 annotation. Indeed, in ORF 36 (see Additional file 1 Figures S5), the smallest ORF containing an evolutionary conserved domain is slightly shorter than the one annotated in 66-p-347 and there is no evidence that the previously annotated methionine is the correct one. However, comparison with homologous genes in other rhadinoviruses suggests that the start codon proposed in the 66-p-347 annotated sequence is the most likely. In ORF 67.5 (see Additional file 1 Figures S6), there is a point substitution in the 66-p-347 annotated ATG leading to the identification of a subsequent ATG as the V.test methionine. Finally, ORF 75 presents a small phase-disrupting indel in its 5' end (see Additional file 1 Figures S9), leading to the absence of the 66-p-347 annotated methionine in the V.test strain. All these annotated genes requested therefore an investigation of their transcription in mRNA products.
As these sequence properties could be specific to the BAC clone of the BoHV-4 V.test strain, we investigated the transcription of these genes on MDBK cells infected with the BoHV-4 V.test WT strain as described in the methods. The primers used are described in Table 1 and highlighted in Additional file 1. For all couple of primers, cDNA from BoHV-4-infected MDBK cells gave rise to the expected PCR products (Figure 3). The absence of contaminant viral DNA in the mRNA preparations was confirmed by a lack of PCR product without reverse transcriptase. The size of the Bo5 RT-PCR product was also consistent with its known mRNA splicing (868 bp rather than 1140 bp). Moreover, the sequences of these RT-PCR products were in agreement with the BoHV-4 V.test sequence derived from our BAC cloned genome (data not shown). Therefore, we can conclude that all these coding sequences are transcribed during BoHV-4 infection of MDBK cells. However, further investigation is needed to determine the presence of proteins and ensure their accurate annotation.
BoHV-4 V.test replication origin
A large region containing the potential lytic replication origin (oriLyt) of the BoHV-4 66-p-347 strain was determined by Zimmermann et al [11]. Based on this information, we mapped this region on the V.test genome (Figure 1). This region contains Bo12, the R2b region and partially overlaps with Bo11. Compared to the 66-p-347 strain sequence, the corresponding region in the V.test genome is highly divergent (Figure 4). Although this region shows high divergence rates, we expected the replication origin to be conserved between the two BoHV-4 strains. Previous work on other herpesviruses has identified in oriLyt the presence of palindromic motifs essential for viral replication [38-40]. When we compared the potential region containing oriLyt in the two strains, a single conserved palindromic region was observed (AATCCAGGCCCCTGATTGGTAGATTGCTGAAAGCCAATCAGGGGCCTGGATT, Figure 4). Interestingly, this region forms a perfect hairpin structure (Figure 4B) that resembles DNA structures formed at other herpesvirus origins [41,42] and may therefore represent a common secondary structure used by all herpesvirus family members during the initiation of DNA replication. In the future, this structure will be tested as a candidate for an essential oriLyt replication motif.
BoHV-4 V.test polyrepetitive DNA
In the BAC clone, previous restriction profiles had determined a hypermolar prDNA band indicating that the BAC contained several prDNA units [12]. Therefore, the major pitfall in the assembly of the BoHV-4 V.test strain was the determination of the prDNA sequence. Indeed, (i) the higher per base coverage on this region due to repetition of prDNA units, (ii) the high GC content, along with (iii) the presence of several long repeats within the prDNA and (iv) the variability observed between prDNA units [14] made it extremely difficult to resolve and assemble with pyrosequencing data alone. Interestingly, it has been shown for several rhadinoviruses that the left junction between the prDNA and the LUR is the site of genome rearrangements and that sequences of the prDNA are found within the first base pairs of the LUR. These properties make this region very difficult to sequence [43-47].
Therefore, we adopted a hybrid strategy consisting in adding some ABI-Sanger reads (with the primers described in Table 1) to guide the 454 assembly on the prDNA region (see Methods).
Bublot, et al. [14] described the different prDNA unit variants present in BoHV-4 V.test, and namely the differences between prDNA units. Firstly, the prDNA units vary according to the number of repetitions of a ~200 bp Pst-I bordered fragment. Secondly, the last prDNA before the prDNA/LUR junction (prDNA-G) displays a different ending than the inner prDNA units [14]. Our method allowed us to disentangle the repeats and to assemble a contig containing a whole prDNA unit (2,440 bp) along with the left prDNA-LUR junction. This prDNA unit, corresponding to prDNA-G following Bublot et al. [14], was extracted from the contig and annotated. A second contig from this hybrid assembly yielded the prDNA/prDNA junction. The presence of the prDNA/prDNA junction in our assembly confirmed the presence of at least two prDNA units in our BAC clone and allowed us to build a complete prDNA-inner unit (see Methods). The assembled prDNA-G and inner prDNA units have sizes of 2,440 bp and 2,607 bp respectively. Both these units are in agreement with their previously published restriction maps [14].
Specifically, we showed that, comparatively to the 66-p-347 strain, the V.test prDNA-inner unit presents several indels including two large indels in the repetitive PstI region (Figure 5). This PstI-rich repetitive region seems to be the one presenting the most variation as it also presents comparatively large differences between prDNA units within the same strain. Indeed, Bublot et al. [14] roughly determined the size of the V.test major prDNA-inner unit to be around 2,650 bp due to the presence of 4 repetitions of the two small PstI bordered fragments.
In the prDNA-G unit, we established that these two small PstI-bordered fragments make up a fragment of 186 bp and that these are indeed repeated 4 times (Figure 6). In the prDNA-inner unit, we determined that the last PstI-bordered fragment is actually a variation of the 186 bp fragment where the inner Pst-I site is slightly modified (Figure 6). Therefore, the rough 200 bp size discrepancy between the prDNA-G (2,440 bp) and the prDNA-inner units (2,607 bp) is due to the presence of a slightly modified repetition of the previous segment. These results are compatible with the restriction profiles presented in Bublot et al. [14] as detailed by the positions of several restriction sites on Figure 6.
In addition to the variations in the PstI-bordered repetitions, one of the major differences between the prDNA-inner units and the prDNA-G lies in their 5' end. Indeed, the prDNA-inner contains a conserved pac-2 cleavage/packaging signal in its right terminal region, which is not the case of prDNA-G (Figure 6). Both units however, possess a conserved pac-1 cleavage/packaging signal in their left terminal region. Interestingly, the pac-1 and pac-2 cleavage and packaging signals show a good conservation between 66-p-347 and V.test's inner units, despite the presence of these signals in a repeated region bearing high divergence levels. Broll et al. [15] have determined, by transient cleavage/packaging assay, that a single prDNA unit is sufficient for cleavage and packaging. However, from the absence of a conserved pac-2 motif in the prDNA-G, we suggest that, even if a single inner prDNA unit is indeed sufficient for cleavage and packaging, the prDNA-G alone would not suffice. This would therefore indicate that two prDNA units at least are necessary in the context of naturally occurring BoHV-4 genomes for correct cleavage and packaging. The packaging of herpesvirus genomes is still not fully understood, however, detailed studies in herpes simplex virus type 1 (HSV-1), human and murine cytomegaloviruses (HCMV and MCMV) have highlighted the roles of the major conserved motifs and suggested the following general mechanism by which concatemers are cleaved and packaged [48-50]. Firstly, the T-box of the pac-2 signal is essential for the cleavage that initiates DNA packaging. Cleavage occurs at a fixed distance from the pac-2 T-box, and the resulting end that contains the pac-2 GC-box and other cis acting elements is inserted into the procapsid. Packaging is therefore directional and proceeds from pac-2 towards the pac-1 terminus [48]. A second cleavage event, directed by pac-1, then terminates DNA packaging. If we apply this model to BoHV-4, the divergence of the pac-2 signal in prDNA-G, namely the absence of a T-box, indicates that it is not a functional pac-2 initiation signal. As the genome packaging is directional from pac-2 to pac-1 (therefore, from the right to the left end of the genome), the lack of a pac-2 initiation signal in prDNA-G ensures that no packaging would lead to a remaining concatemer lacking a left end prDNA. This would therefore guarantee that genomes bearing at least one left and one right end prDNA unit are encapsulated into virions. This model and its implications will require further investigations in the future.
Conclusions
BAC-cloning of the BoHV-4 V.test strain has greatly facilitated the use of this virus as a model for human pathogenic gammaherpesviruses. However, until now, the complete genome sequence of this strain was unavailable. In this study, we have determined the complete genome sequence of the BoHV-4 V.test strain. In comparison with the previously sequenced 66-p-347 strain, we identified important differences in 9 potential open reading frames. Moreover, sequence analyses allowed us to identify genome features that are potentially important for viral replication. All together, these results should have implications for the study of BoHV-4 and herpesviruses in general.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
LP analyzed the data in silico, participated in the RT-PCR assay and drafted the manuscript. BM prepared the viral DNA, participated in data analysis and performed the RT-PCR assay. AV and CL participated in data analysis. LG analyzed the data and drafted the manuscript. All authors read and approved the final manuscript.
Supplementary Material
Contributor Information
Leonor Palmeira, Email: mlpalmeira@ulg.ac.be.
Bénédicte Machiels, Email: bmachiels@ulg.ac.be.
Céline Lété, Email: celine.lete@ulg.ac.be.
Alain Vanderplasschen, Email: a.vdplasschen@ulg.ac.be.
Laurent Gillet, Email: l.gillet@ulg.ac.be.
Acknowledgements
LP is supported by a post-doctoral fellowship from the University of Liège. BM, CL and LG are Research Fellows and Research Associate of the "Fonds de la Recherche Scientifique - Fonds National Belge de la Recherche Scientifique" (F.R.S. - FNRS), respectively. This work was supported by the following grants: starting grant (D-09/11) and GLYVIR ARC of the University of Liège and scientific impulse grant of the F.R.S. - FNRS n°F.4510.10.
References
- Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, Kirya BG, Klein G, Morrow RH, Munube GM, Pike P. et al. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst. 1969;43:1147–1157. [PubMed] [Google Scholar]
- Verma SC, Robertson ES. Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiol Lett. 2003;222:155–163. doi: 10.1016/S0378-1097(03)00261-1. [DOI] [PubMed] [Google Scholar]
- Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004;350:1328–1337. doi: 10.1056/NEJMra032015. [DOI] [PubMed] [Google Scholar]
- Davison AJ, Eberle R, Ehlers B, Hayward GS, McGeoch DJ, Minson AC, Pellett PE, Roizman B, Studdert MJ, Thiry E. The order Herpesvirales. Arch Virol. 2009;154:171–177. doi: 10.1007/s00705-008-0278-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thiry E, Bublot M, Dubuisson J, Van Bressem MF, Lequarre AS, Lomonte P, Vanderplasschen A, Pastoret PP. Molecular biology of bovine herpesvirus type 4. Vet Microbiol. 1992;33:79–92. doi: 10.1016/0378-1135(92)90037-T. [DOI] [PubMed] [Google Scholar]
- Bartha A, Juhasz M, Liebermann H. Isolation of a bovine herpesvirus from calves with respiratory disease and keratoconjunctivitis. A preliminary report. Acta Vet Acad Sci Hung. 1966;16:357–358. [PubMed] [Google Scholar]
- Mohanty SB, Hammond RC, Lillie MG. A new bovine herpesvirus and its effect on experimentally infected calves. Brief report. Arch Gesamte Virusforsch. 1971;33:394–395. doi: 10.1007/BF01254696. [DOI] [PubMed] [Google Scholar]
- Rossiter PB, Gumm ID, Stagg DA, Conrad PA, Mukolwe S, Davies FG, White H. Isolation of bovine herpesvirus-3 from African buffaloes (Syncerus caffer) Res Vet Sci. 1989;46:337–343. [PubMed] [Google Scholar]
- Dewals B, Thirion M, Markine-Goriaynoff N, Gillet L, de Fays K, Minner F, Daix V, Sharp PM, Vanderplasschen A. Evolution of Bovine herpesvirus 4: recombination and transmission between African buffalo and cattle. J Gen Virol. 2006;87:1509–1519. doi: 10.1099/vir.0.81757-0. [DOI] [PubMed] [Google Scholar]
- Dewals B, Gillet L, Gerdes T, Taracha EL, Thiry E, Vanderplasschen A. Antibodies against bovine herpesvirus 4 are highly prevalent in wild African buffaloes throughout eastern and southern Africa. Vet Microbiol. 2005;110:209–220. doi: 10.1016/j.vetmic.2005.08.006. [DOI] [PubMed] [Google Scholar]
- Zimmermann W, Broll H, Ehlers B, Buhk HJ, Rosenthal A, Goltz M. Genome sequence of bovine herpesvirus 4, a bovine Rhadinovirus, and identification of an origin of DNA replication. J Virol. 2001;75:1186–1194. doi: 10.1128/JVI.75.3.1186-1194.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gillet L, Daix V, Donofrio G, Wagner M, Koszinowski UH, China B, Ackermann M, Markine-Goriaynoff N, Vanderplasschen A. Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning. J Gen Virol. 2005;86:907–917. doi: 10.1099/vir.0.80718-0. [DOI] [PubMed] [Google Scholar]
- Thiry E, Pastoret PP, Dessy-Doizé C, Hanzen C, Calberg-Bacq CM. Herpesvirus in infertile bull's testicle. Vet rec. 1981;108:426. doi: 10.1136/vr.108.19.426. [DOI] [PubMed] [Google Scholar]
- Bublot M, Van Bressem MF, Thiry E, Dubuisson J, Pastoret PP. Bovine herpesvirus 4 genome: cloning, mapping and strain variation analysis. J Gen Virol. 1990;71(Pt 1):133–142. doi: 10.1099/0022-1317-71-1-133. [DOI] [PubMed] [Google Scholar]
- Broll H, Buhk HJ, Zimmermann W, Goltz M. Structure and function of the prDNA and the genomic termini of the gamma2-herpesvirus bovine herpesvirus type 4. J Gen Virol. 1999;80(Pt 4):979–986. doi: 10.1099/0022-1317-80-4-979. [DOI] [PubMed] [Google Scholar]
- Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen YJ, Chen Z. et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature. 2005;437:376–380. doi: 10.1038/nature03959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403–410. doi: 10.1016/S0022-2836(05)80360-2. [DOI] [PubMed] [Google Scholar]
- Lomonte P, Bublot M, van Santen V, Keil GM, Pastoret PP, Thiry E. Analysis of bovine herpesvirus 4 genomic regions located outside the conserved gammaherpesvirus gene blocks. J Gen Virol. 1995;76(Pt 7):1835–1841. doi: 10.1099/0022-1317-76-7-1835. [DOI] [PubMed] [Google Scholar]
- Chevreux B, Pfisterer T, Drescher B, Driesel AJ, Muller WE, Wetter T, Suhai S. Using the miraEST assembler for reliable and automated mRNA transcript assembly and SNP detection in sequenced ESTs. Genome Res. 2004;14:1147–1159. doi: 10.1101/gr.1917404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ewing B, Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998;8:186–194. [PubMed] [Google Scholar]
- Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 1998;8:175–185. doi: 10.1101/gr.8.3.175. [DOI] [PubMed] [Google Scholar]
- Chou HH, Holmes MH. DNA sequence quality trimming and vector removal. Bioinformatics. 2001;17:1093–1104. doi: 10.1093/bioinformatics/17.12.1093. [DOI] [PubMed] [Google Scholar]
- Staden R, Beal KF, Bonfield JK. The Staden package, 1998. Methods Mol Biol. 2000;132:115–130. doi: 10.1385/1-59259-192-2:115. [DOI] [PubMed] [Google Scholar]
- Marchler-Bauer A, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M. et al. CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Res. 2009;37:D205–210. doi: 10.1093/nar/gkn845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schaffer AA, Wolf YI, Ponting CP, Koonin EV, Aravind L, Altschul SF. IMPALA: matching a protein sequence against a collection of PSI-BLAST-constructed position-specific score matrices. Bioinformatics. 1999;15:1000–1011. doi: 10.1093/bioinformatics/15.12.1000. [DOI] [PubMed] [Google Scholar]
- Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R. et al. Clustal W and Clustal × version 2.0. Bioinformatics. 2007;23:2947–2948. doi: 10.1093/bioinformatics/btm404. [DOI] [PubMed] [Google Scholar]
- Team RDC. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2010. [Google Scholar]
- Charif D, Lobry J. SeqinR 1.0-2: a contributed package to the R project for statistical computing devoted to biological sequences retrieval and analysis. New York: Springer Verlag; 2007. [Google Scholar]
- Cock PJ, Antao T, Chang JT, Chapman BA, Cox CJ, Dalke A, Friedberg I, Hamelryck T, Kauff F, Wilczynski B, de Hoon MJ. Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics. 2009;25:1422–1423. doi: 10.1093/bioinformatics/btp163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Rossum G, Drake F. , Jr. The Python Language Reference Manual (version 2.5) Network Theory Ltd; 2006. [Google Scholar]
- Machiels B, Lete C, de Fays K, Mast J, Dewals B, Stevenson PG, Vanderplasschen A, Gillet L. Bovine Herpesvirus-4 Bo10 gene encodes a non-essential viral envelope protein that regulates viral tropism through both positive and negative effects. J Virol. 2010. [DOI] [PMC free article] [PubMed]
- Spatz SJ, Rue CA. Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing. Virus Genes. 2008;36:479–489. doi: 10.1007/s11262-008-0213-5. [DOI] [PubMed] [Google Scholar]
- Elsik CG, Tellam RL, Worley KC, Gibbs RA, Muzny DM, Weinstock GM, Adelson DL, Eichler EE, Elnitski L, Guigo R. et al. The genome sequence of taurine cattle: a window to ruminant biology and evolution. Science. 2009;324:522–528. doi: 10.1126/science.1169588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wicker T, Schlagenhauf E, Graner A, Close TJ, Keller B, Stein N. 454 sequencing put to the test using the complex genome of barley. BMC Genomics. 2006;7:275. doi: 10.1186/1471-2164-7-275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walz N, Christalla T, Tessmer U, Grundhoff A. A global analysis of evolutionary conservation among known and predicted gammaherpesvirus microRNAs. J Virol. 2010;84:716–728. doi: 10.1128/JVI.01302-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fu M, Deng R, Wang J, Wang X. Detection and analysis of horizontal gene transfer in herpesvirus. Virus Res. 2008;131:65–76. doi: 10.1016/j.virusres.2007.08.009. [DOI] [PubMed] [Google Scholar]
- Vanderplasschen A, Markine-Goriaynoff N, Lomonte P, Suzuki M, Hiraoka N, Yeh JC, Bureau F, Willems L, Thiry E, Fukuda M, Pastoret PP. A multipotential beta -1,6-N-acetylglucosaminyl-transferase is encoded by bovine herpesvirus type 4. Proc Natl Acad Sci USA. 2000;97:5756–5761. doi: 10.1073/pnas.100058897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Portes-Sentis S, Sergeant A, Gruffat H. A particular DNA structure is required for the function of a cis-acting component of the Epstein-Barr virus OriLyt origin of replication. Nucleic Acids Res. 1997;25:1347–1354. doi: 10.1093/nar/25.7.1347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu Y, Huang L, Anders DG. Human cytomegalovirus oriLyt sequence requirements. J Virol. 1998;72:4989–4996. doi: 10.1128/jvi.72.6.4989-4996.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- AuCoin DP, Colletti KS, Xu Y, Cei SA, Pari GS. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replication. J Virol. 2002;76:7890–7896. doi: 10.1128/JVI.76.15.7890-7896.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rennekamp AJ, Wang P, Lieberman PM. Evidence for DNA hairpin recognition by Zta at the Epstein-Barr virus origin of lytic replication. J Virol. 2010;84:7073–7082. doi: 10.1128/JVI.02666-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aslani A, Macao B, Simonsson S, Elias P. Complementary intrastrand base pairing during initiation of Herpes simplex virus type 1 DNA replication. Proc Natl Acad Sci USA. 2001;98:7194–7199. doi: 10.1073/pnas.121177198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) Proc Natl Acad Sci USA. 1996;93:14862–14867. doi: 10.1073/pnas.93.25.14862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Searles RP, Bergquam EP, Axthelm MK, Wong SW. Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol. 1999;73:3040–3053. doi: 10.1128/jvi.73.4.3040-3053.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stamminger T, Honess RW, Young DF, Bodemer W, Blair ED, Fleckenstein B. Organization of terminal reiterations in the virion DNA of herpesvirus saimiri. J Gen Virol. 1987;68(Pt 4):1049–1066. doi: 10.1099/0022-1317-68-4-1049. [DOI] [PubMed] [Google Scholar]
- Lagunoff M, Ganem D. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology. 1997;236:147–154. doi: 10.1006/viro.1997.8713. [DOI] [PubMed] [Google Scholar]
- Albrecht JC, Nicholas J, Biller D, Cameron KR, Biesinger B, Newman C, Wittmann S, Craxton MA, Coleman H, Fleckenstein B. et al. Primary structure of the herpesvirus saimiri genome. J Virol. 1992;66:5047–5058. doi: 10.1128/jvi.66.8.5047-5058.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tong L, Stow ND. Analysis of herpes simplex virus type 1 DNA packaging signal mutations in the context of the viral genome. J Virol. 2010;84:321–329. doi: 10.1128/JVI.01489-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang JB, McVoy MA. A 128-Base-Pair Sequence Containing the pac1 and a Presumed Cryptic pac2 Sequence Includes cis Elements Sufficient To Mediate Efficient Genome Maturation of Human Cytomegalovirus. J Virol. 2011;85:4432–4439. doi: 10.1128/JVI.02307-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McVoy MA, Nixon DE, Hur JK, Adler SP. The ends on herpesvirus DNA replicative concatemers contain pac2 cis cleavage/packaging elements and their formation is controlled by terminal cis sequences. J Virol. 2000;74:1587–1592. doi: 10.1128/JVI.74.3.1587-1592.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.